Yakira Capital Management, Inc. Seagen Inc. Transaction History

Yakira Capital Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$191.51 - $216.16 $7.87 Million - $8.88 Million	41,100 Added 140.75%	70,300 $14.9 Million
Q2 2023 Aug 11, 2023	BUY	$187.64 - $206.25 $5.48 Million - $6.02 Million	29,200 New	29,200 $5.62 Million
Q4 2022 Feb 10, 2023	BUY	$117.37 - $139.17 $29,342 - $34,792	250 Added 0.97%	26,060 $3.35 Million
Q3 2022 Nov 10, 2022	BUY	$135.27 - $180.11 $3.49 Million - $4.65 Million	25,810 New	25,810 $3.53 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Yakira Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Yakira Capital Management, Inc. with notifications on news.